世界のエルタペネム注射市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Ertapenem Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z05223 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、エルタペネム注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エルタペネム注射の種類別市場規模（1g /バイアル、その他）、用途別市場規模（成人、小児）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エルタペネム注射の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Endo、Aurobindo Pharma、ACS Dobfar ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：1g /バイアル、その他 ・用途別分析2016年-2026年：成人、小児 ・エルタペネム注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エルタペネム注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エルタペネム注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エルタペネム注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エルタペネム注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Ertapenem Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Ertapenem Injection size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Ertapenem Injection market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Ertapenem Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
1g/Vial
Others

Market segment by Application can be divided into
Adult
Pediatric

The key market players for global Ertapenem Injection market are listed below:
Merck
Endo
Aurobindo Pharma
ACS Dobfar

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Ertapenem Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ertapenem Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 1g/Vial
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Ertapenem Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Ertapenem Injection Market Size & Forecast
1.4.1 Global Ertapenem Injection Sales in Value (2016-2026))
1.4.2 Global Ertapenem Injection Sales in Volume (2016-2026)
1.4.3 Global Ertapenem Injection Price by Type (2016-2026) & (USD/Unit)
1.5 Global Ertapenem Injection Production Capacity Analysis
1.5.1 Global Ertapenem Injection Total Production Capacity (2016-2026)
1.5.2 Global Ertapenem Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ertapenem Injection Market Drivers
1.6.2 Ertapenem Injection Market Restraints
1.6.3 Ertapenem Injection Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Ertapenem Injection Product and Services
2.1.4 Merck Ertapenem Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Endo
2.2.1 Endo Details
2.2.2 Endo Major Business
2.2.3 Endo Ertapenem Injection Product and Services
2.2.4 Endo Ertapenem Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Aurobindo Pharma
2.3.1 Aurobindo Pharma Details
2.3.2 Aurobindo Pharma Major Business
2.3.3 Aurobindo Pharma Ertapenem Injection Product and Services
2.3.4 Aurobindo Pharma Ertapenem Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 ACS Dobfar
2.4.1 ACS Dobfar Details
2.4.2 ACS Dobfar Major Business
2.4.3 ACS Dobfar Ertapenem Injection Product and Services
2.4.4 ACS Dobfar Ertapenem Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Ertapenem Injection Sales by Manufacturer
3.1 Global Ertapenem Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Ertapenem Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Ertapenem Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Ertapenem Injection Manufacturer Market Share
3.4.2 Top 6 Ertapenem Injection Manufacturer Market Share
3.5 Global Ertapenem Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Ertapenem Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ertapenem Injection Market Size by Region
4.1.1 Global Ertapenem Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Ertapenem Injection Revenue by Region (2016-2026)
4.2 North America Ertapenem Injection Revenue (2016-2026)
4.3 Europe Ertapenem Injection Revenue (2016-2026)
4.4 Asia-Pacific Ertapenem Injection Revenue (2016-2026)
4.5 South America Ertapenem Injection Revenue (2016-2026)
4.6 Middle East and Africa Ertapenem Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Ertapenem Injection Sales in Volume by Type (2016-2026)
5.2 Global Ertapenem Injection Revenue by Type (2016-2026)
5.3 Global Ertapenem Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Ertapenem Injection Sales in Volume by Application (2016-2026)
6.2 Global Ertapenem Injection Revenue by Application (2016-2026)
6.3 Global Ertapenem Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Ertapenem Injection Sales by Type (2016-2026)
7.2 North America Ertapenem Injection Sales by Application (2016-2026)
7.3 North America Ertapenem Injection Market Size by Country
7.3.1 North America Ertapenem Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Ertapenem Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Ertapenem Injection Sales by Type (2016-2026)
8.2 Europe Ertapenem Injection Sales by Application (2016-2026)
8.3 Europe Ertapenem Injection Market Size by Country
8.3.1 Europe Ertapenem Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Ertapenem Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Ertapenem Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Ertapenem Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Ertapenem Injection Market Size by Region
9.3.1 Asia-Pacific Ertapenem Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Ertapenem Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Ertapenem Injection Sales by Type (2016-2026)
10.2 South America Ertapenem Injection Sales by Application (2016-2026)
10.3 South America Ertapenem Injection Market Size by Country
10.3.1 South America Ertapenem Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Ertapenem Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ertapenem Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Ertapenem Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Ertapenem Injection Market Size by Country
11.3.1 Middle East & Africa Ertapenem Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Ertapenem Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Ertapenem Injection Typical Distributors
12.3 Ertapenem Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Ertapenem Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Ertapenem Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Ertapenem Injection Product and Services
Table 6. Merck Ertapenem Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Endo Basic Information, Manufacturing Base and Competitors
Table 8. Endo Major Business
Table 9. Endo Ertapenem Injection Product and Services
Table 10. Endo Ertapenem Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Aurobindo Pharma Major Business
Table 13. Aurobindo Pharma Ertapenem Injection Product and Services
Table 14. Aurobindo Pharma Ertapenem Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. ACS Dobfar Basic Information, Manufacturing Base and Competitors
Table 16. ACS Dobfar Major Business
Table 17. ACS Dobfar Ertapenem Injection Product and Services
Table 18. ACS Dobfar Ertapenem Injection Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Ertapenem Injection Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Ertapenem Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Ertapenem Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Ertapenem Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Ertapenem Injection Production Site of Key Manufacturer
Table 24. Global Ertapenem Injection Sales by Region (2016-2021e) & (K Units)
Table 25. Global Ertapenem Injection Sales by Region (2021-2026) & (K Units)
Table 26. Global Ertapenem Injection Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Ertapenem Injection Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Ertapenem Injection Sales by Type (2016-2021e) & (K Units)
Table 29. Global Ertapenem Injection Sales by Type (2021-2026) & (K Units)
Table 30. Global Ertapenem Injection Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Ertapenem Injection Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Ertapenem Injection Price by Type (2016-2021e) & (USD/Unit)
Table 33. Global Ertapenem Injection Price by Type (2021-2026) & (USD/Unit)
Table 34. Global Ertapenem Injection Sales by Application (2016-2021e) & (K Units)
Table 35. Global Ertapenem Injection Sales by Application (2021-2026) & (K Units)
Table 36. Global Ertapenem Injection Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Ertapenem Injection Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Ertapenem Injection Price by Application (2016-2021e) & (USD/Unit)
Table 39. Global Ertapenem Injection Price by Application (2021-2026) & (USD/Unit)
Table 40. North America Ertapenem Injection Sales by Country (2016-2021e) & (K Units)
Table 41. North America Ertapenem Injection Sales by Country (2021-2026) & (K Units)
Table 42. North America Ertapenem Injection Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Ertapenem Injection Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Ertapenem Injection Sales by Type (2016-2021e) & (K Units)
Table 45. North America Ertapenem Injection Sales by Type (2021-2026) & (K Units)
Table 46. North America Ertapenem Injection Sales by Application (2016-2021e) & (K Units)
Table 47. North America Ertapenem Injection Sales by Application (2021-2026) & (K Units)
Table 48. Europe Ertapenem Injection Sales by Country (2016-2021e) & (K Units)
Table 49. Europe Ertapenem Injection Sales by Country (2021-2026) & (K Units)
Table 50. Europe Ertapenem Injection Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Ertapenem Injection Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Ertapenem Injection Sales by Type (2016-2021e) & (K Units)
Table 53. Europe Ertapenem Injection Sales by Type (2021-2026) & (K Units)
Table 54. Europe Ertapenem Injection Sales by Application (2016-2021e) & (K Units)
Table 55. Europe Ertapenem Injection Sales by Application (2021-2026) & (K Units)
Table 56. Asia-Pacific Ertapenem Injection Sales by Region (2016-2021e) & (K Units)
Table 57. Asia-Pacific Ertapenem Injection Sales by Region (2021-2026) & (K Units)
Table 58. Asia-Pacific Ertapenem Injection Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Ertapenem Injection Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Ertapenem Injection Sales by Type (2016-2021e) & (K Units)
Table 61. Asia-Pacific Ertapenem Injection Sales by Type (2021-2026) & (K Units)
Table 62. Asia-Pacific Ertapenem Injection Sales by Application (2016-2021e) & (K Units)
Table 63. Asia-Pacific Ertapenem Injection Sales by Application (2021-2026) & (K Units)
Table 64. South America Ertapenem Injection Sales by Country (2016-2021e) & (K Units)
Table 65. South America Ertapenem Injection Sales by Country (2021-2026) & (K Units)
Table 66. South America Ertapenem Injection Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Ertapenem Injection Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Ertapenem Injection Sales by Type (2016-2021e) & (K Units)
Table 69. South America Ertapenem Injection Sales by Type (2021-2026) & (K Units)
Table 70. South America Ertapenem Injection Sales by Application (2016-2021e) & (K Units)
Table 71. South America Ertapenem Injection Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Ertapenem Injection Sales by Country (2016-2021e) & (K Units)
Table 73. Middle East & Africa Ertapenem Injection Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Ertapenem Injection Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Ertapenem Injection Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Ertapenem Injection Sales by Type (2016-2021e) & (K Units)
Table 77. Middle East & Africa Ertapenem Injection Sales by Type (2021-2026) & (K Units)
Table 78. Middle East & Africa Ertapenem Injection Sales by Application (2016-2021e) & (K Units)
Table 79. Middle East & Africa Ertapenem Injection Sales by Application (2021-2026) & (K Units)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Ertapenem Injection Typical Distributors
Table 83. Ertapenem Injection Typical Customers
List of Figures
Figure 1. Ertapenem Injection Picture
Figure 2. Global Ertapenem Injection Sales Market Share by Type in 2020
Figure 3. 1g/Vial
Figure 4. Others
Figure 5. Global Ertapenem Injection Sales Market Share by Application in 2020
Figure 6. Adult
Figure 7. Pediatric
Figure 8. Global Ertapenem Injection Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Ertapenem Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Ertapenem Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Ertapenem Injection Sales (2016-2026) & (K Units)
Figure 30. Global Ertapenem Injection Production Capacity (2016-2026) & (K Units)
Figure 31. Global Ertapenem Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Ertapenem Injection Market Drivers
Figure 33. Ertapenem Injection Market Restraints
Figure 34. Ertapenem Injection Market Trends
Figure 35. Global Ertapenem Injection Sales Market Share by Manufacturer in 2020
Figure 36. Global Ertapenem Injection Revenue Market Share by Manufacturer in 2020
Figure 37. Ertapenem Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Ertapenem Injection Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Ertapenem Injection Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Ertapenem Injection Sales Market Share by Region (2016-2026)
Figure 41. Global Ertapenem Injection Revenue Market Share by Region (2016-2026)
Figure 42. North America Ertapenem Injection Revenue (2016-2026) & (USD Million)
Figure 43. Europe Ertapenem Injection Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Ertapenem Injection Revenue (2016-2026) & (USD Million)
Figure 45. South America Ertapenem Injection Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Ertapenem Injection Revenue (2016-2026) & (USD Million)
Figure 47. Global Ertapenem Injection Sales Market Share by Type (2016-2026)
Figure 48. Global Ertapenem Injection Revenue Market Share by Type (2016-2026)
Figure 49. Global Ertapenem Injection Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Ertapenem Injection Sales Market Share by Application (2016-2026)
Figure 51. Global Ertapenem Injection Revenue Market Share by Application (2016-2026)
Figure 52. Global Ertapenem Injection Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Ertapenem Injection Sales Market Share by Country (2016-2026)
Figure 54. North America Ertapenem Injection Revenue Market Share by Country (2016-2026)
Figure 55. North America Ertapenem Injection Sales Market Share by Type (2016-2026)
Figure 56. North America Ertapenem Injection Sales Market Share by Application (2016-2026)
Figure 57. Europe Ertapenem Injection Sales Market Share by Country (2016-2026)
Figure 58. Europe Ertapenem Injection Revenue Market Share by Country (2016-2026)
Figure 59. Europe Ertapenem Injection Sales Market Share by Type (2016-2026)
Figure 60. Europe Ertapenem Injection Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Ertapenem Injection Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Ertapenem Injection Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Ertapenem Injection Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Ertapenem Injection Sales Market Share by Application (2016-2026)
Figure 65. South America Ertapenem Injection Sales Market Share by Country (2016-2026)
Figure 66. South America Ertapenem Injection Revenue Market Share by Country (2016-2026)
Figure 67. South America Ertapenem Injection Sales Market Share by Type (2016-2026)
Figure 68. South America Ertapenem Injection Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Ertapenem Injection Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Ertapenem Injection Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Ertapenem Injection Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Ertapenem Injection Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source

---